FTUG has started its own testing facility in India to provide cost efficient testing and development services . FTUG has its 5000 sq. ft. facility at its Navi Mumbai site dedicated for product development and testing services. FTUG’s laboratory is in compliance with 21 CFR and EMA good manufacturing requirements.
FTUG has submitted ANDA for Prasugrel Hydrochloride under paragraph IV patent certification.
FTUG is established in year 2013 , within two years successfully developed 4 products and submitted ANDAs under Paragraph IV certification and all the ANDAs are accepted as first to file. FTUG’s several development projects are in pipeline.
In 2014 FTUG has formed its subsidiary company in India to provide cost efficient services to pharmaceutical companies.
Currently, FTUG owns its own manufacturing facility in Philadelphia. FTUG has its state of art research and development center in Mumbai India, which is spread over 5000 sq. ft. This facility is in compliance with FDA and EU GMP standards.
FTUG’s research center in India provides product development, analytical method development and validation , impurity profiling, stability and release testing services.